Literature DB >> 26195206

Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy.

Parth J Parekh1, Luis A Balart2.   

Abstract

Hepatic encephalopathy (HE) is a commonly encountered sequela of chronic liver disease and cirrhosis with significant associated morbidity and mortality. Although ammonia is implicated in the pathogenesis of HE, the exact underlying mechanisms still remain poorly understood. Its role in the urea cycle, astrocyte swelling, and glutamine and gamma-amino-n-butyric acid systems suggests that the pathogenesis is multifaceted. Greater understanding in its underlying mechanism may offer more targeted therapeutic options in the future, and thus further research is necessary to fully understand the pathogenesis of HE.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ammonia; Astrocyte swelling; GABA; Glutamate; Glutamine; Hepatic encephalopathy; Urea cycle

Mesh:

Substances:

Year:  2015        PMID: 26195206     DOI: 10.1016/j.cld.2015.05.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  21 in total

1.  Construction and comprehensive analysis of a lncRNA-mRNA interactive network to reveal a potential lncRNA for hepatic encephalopathy development.

Authors:  Chihao Zhang; Wei Ni; Yiming Zhu; Jiayun Lin; Hongjie Li; Zhifeng Zhao; Ke Wang; Haizhong Huo; Meng Luo
Journal:  Hum Cell       Date:  2022-05-18       Impact factor: 4.174

2.  Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model.

Authors:  Heba M A Khalil; Islam A Khalil; Asmaa K Al-Mokaddem; Marwa Hassan; Riham A El-Shiekh; Hesham A Eliwa; Azza M Tawfek; Walaa H El-Maadawy
Journal:  Drug Deliv Transl Res       Date:  2022-06-07       Impact factor: 4.617

3.  Therapeutic potential of probiotics - Lactobacillus plantarum UBLP40 and Bacillus clausii UBBC07 on thioacetamide-induced acute hepatic encephalopathy in rats.

Authors:  Lalita Shahgond; Chirag Patel; Khushboo Thakur; Dipta Sarkar; Sanjeev Acharya; Priyanshi Patel
Journal:  Metab Brain Dis       Date:  2021-11-03       Impact factor: 3.584

Review 4.  What we know: the inflammatory basis of hepatic encephalopathy.

Authors:  K Milewski; M Oria
Journal:  Metab Brain Dis       Date:  2015-10-26       Impact factor: 3.584

5.  Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice.

Authors:  Long Cheng; Xiaoying Wang; Xueni Ma; Huimei Xu; Yifan Yang; Dekui Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.

Authors:  Krzysztof Milewski; Małgorzata Bogacińska-Karaś; Inez Fręśko; Wojciech Hilgier; Radosław Jaźwiec; Jan Albrecht; Magdalena Zielińska
Journal:  Int J Mol Sci       Date:  2017-11-02       Impact factor: 5.923

Review 7.  Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions.

Authors:  Duminda Suraweera; Vinay Sundaram; Sammy Saab
Journal:  Gut Liver       Date:  2016-07-15       Impact factor: 4.519

Review 8.  Recent advances in hepatic encephalopathy.

Authors:  Victoria Liere; Gurkarminder Sandhu; Sharon DeMorrow
Journal:  F1000Res       Date:  2017-09-04

9.  Aloin Inhibits Müller Cells Swelling in a Rat Model of Thioacetamide-Induced Hepatic Retinopathy.

Authors:  Eunsoo Jung; Junghyun Kim
Journal:  Molecules       Date:  2018-10-29       Impact factor: 4.411

10.  Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.

Authors:  Jia Zhu; Xingshun Qi; Haonan Yu; Eric M Yoshida; Nahum Mendez-Sanchez; Xintong Zhang; Ran Wang; Han Deng; Jing Li; Dan Han; Xiaozhong Guo
Journal:  United European Gastroenterol J       Date:  2018-04-23       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.